Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation for the Secondary Prevention of Stroke: A Subgroup Analysis of J-ROCKET AF by Tanahashi, Norio, MD, PhD, Hori, Masatsugu, MD, PhD, Matsumoto, Masayasu, MD, PhD, Momomura, Shin-ichi, MD, Uchiyama, Shinichiro, MD, PhD, Goto, Shinya, MD, PhD, Izumi, Tohru, MD, PhD, Koretsune, Yukihiro, MD, PhD, Kajikawa, Mariko, MD, PhD, Kato, Masaharu, MSc, Ueda, Hitoshi, PhD, Iwamoto, Kazuya, MD, PhD, Tajiri, Masahiro, BSc

Get full text

Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation in Relation to the CHADS2 Score: A Subgroup Analysis of the J-ROCKET AF Trial by Hori, Masatsugu, MD, PhD, Matsumoto, Masayasu, MD, PhD, Tanahashi, Norio, MD, Momomura, Shin-ichi, MD, Uchiyama, Shinichiro, MD, PhD, Goto, Shinya, MD, PhD, Izumi, Tohru, MD, PhD, Koretsune, Yukihiro, MD, PhD, Kajikawa, Mariko, MD, PhD, Kato, Masaharu, MSc, Ueda, Hitoshi, PhD, Iekushi, Kazuma, MD, PhD, Yamanaka, Satoshi, MD, PhD, Tajiri, Masahiro, BSc

Get full text

Net Clinical Benefit of Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation: A Subgroup Analysis of J-ROCKET AF by Uchiyama, Shinichiro, MD, PhD, Hori, Masatsugu, MD, PhD, Matsumoto, Masayasu, MD, PhD, Tanahashi, Norio, MD, PhD, Momomura, Shin-ichi, MD, Goto, Shinya, MD, PhD, Izumi, Tohru, MD, PhD, Koretsune, Yukihiro, MD, PhD, Kajikawa, Mariko, MD, PhD, Kato, Masaharu, MSc, Ueda, Hitoshi, PhD, Iekushi, Kazuma, MD, PhD, Yamanaka, Satoshi, MD, PhD, Tajiri, Masahiro, BSc

Get full text